In 2023, The American Cancer Society launched ACS CARES (Community Access to Resources, Education, and Support), a new multi-channel, customizable program that delivers non-clinical patient navigation support to cancer patients and caregivers. Through a convenient mobile app and personalized support from trained American Cancer Society volunteers, it equips those facing cancer with curated information, resources and patient navigation support personalized to their specific cancer journey.
Patient navigation helps people with cancer deal with barriers they may encounter at the time of diagnosis, during treatment, and into survivorship. More than 2.1 million people are expected to be diagnosed with cancer this year. After diagnosis, many will face uncertainty about next steps and finding accurate information. The ACS CARES mobile app provides patients and caregivers an easy, free way to:
Cancer affects many of us, including our own professionals and families. Patients and families face challenges when it comes to prevention and treatment, and navigating those challenges is critical for better health outcomes, all while working to eliminate the health inequities that exist. We are pleased to collaborate with ACS in bringing an innovative, tech-enabled approach to the patient experience, blending relevant content, staff-assisted navigation, and virtual/in-person support. ACS’s personalized approach, leveraging community relationships, allows us to together drive impact on a national scale. Health equity is a moral and business imperative. Every organization, across every industry, can play a role in making health more equitable – within their organizations, and in the communities they serve.
With this collaboration, and a $1 million commitment, to be used over two years, the Deloitte* Health Equity Institute (DHEI) together with ACS will expand the program to focus on:
*Please see www.deloitte.com/us/about for a detailed description of their legal structure.
*Any link provided to websites of other companies are for convenience and are not an endorsement of a service or product.